🌍·Jan 1, 1970Research
Redirection of sphingolipid metabolism drives cytoskeletal defects in SPLIS and reveals ROCK inhibition as therapy
Publisher
J
Journal of Clinical Investigation
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Journal of Clinical Investigation
- Region
- Global
- Scope
- Research
- Published
- January 1, 1970
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on jci.org
Leave the platform to read the original full article on the publisher site.
Source: Journal of Clinical Investigation
Scope: Research
Related coverage
More related coverage
Universitätsklinikum Heidelberg/5h ago
COPLANT-Studie begrüßt 3.000. Teilnehmerin in Heidelberg
Northwestern Medicine/7h ago
Suburban Woman Reclaims Her Voice with Help from the Northwestern Medicine Aphasia Center at Marianjoy Rehabilitation Hospital
Universitätsklinikum Heidelberg/8h ago
Chronische Darmbeschwerden: Von der Diagnose zur modernen Therapie
UNMC/9h ago